Organogenesis Inc.
ORGO | NASDAQ
$1.40
-$0.02 (-1.41%)
At close: Sep 21, 2026, 4:00 PM ET
$1.59
+$0.19 (+13.57%)
Pre-market:
Sep 22, 2026, 6:11 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 563.03M | 482.04M | 433.14M | 450.89M | 467.36M | 338.3M |
Cost of Revenue | 137.52M | 115.74M | 106.48M | 105.02M | 114.2M | 87.32M |
Gross Profit | 425.51M | 366.3M | 326.66M | 345.87M | 353.16M | 250.98M |
Operating Income | 55.87M | -1.28M | 12.53M | 22.3M | 72.22M | 26.7M |
Interest Income | 2.28M | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 46.97M | -2.81M | 10.39M | 20.28M | 63.09M | 17.76M |
Net Income | 37.03M | 861K | 4.95M | 15.53M | 94.2M | 17.23M |
Selling & General & Admin | 326.24M | 294.51M | 269.75M | 283.81M | 250.2M | 204.19M |
Research & Development | 44.54M | 50.27M | 44.38M | 39.76M | 30.74M | 20.09M |
Other Expenses | -1.14M | 22.8M | n/a | n/a | n/a | n/a |
Operating Expenses | 369.64M | 367.59M | 314.13M | 323.57M | 280.94M | 224.28M |
Interest Expense | n/a | 1.54M | 2.19M | 2.01M | 7.24M | 11.28M |
Selling & Marketing Expenses | n/a | 3.83M | 5.23M | 4.81M | n/a | n/a |
Cost & Expenses | 507.16M | 483.33M | 420.62M | 428.59M | 395.14M | 311.6M |
Income Tax Expense | 9.94M | -3.67M | 5.45M | 4.75M | -31.12M | 530K |
Shares Outstanding (Basic) | 126.74M | 131.67M | 131.23M | 130.07M | 128.33M | 107.74M |
Shares Outstanding (Diluted) | 130.25M | 131.67M | 132.75M | 132.38M | 133.66M | 111.36M |
EPS (Basic) | 0.16 | -0.01 | 0.04 | 0.12 | 0.73 | 0.16 |
EPS (Diluted) | 0.15 | -0.01 | 0.04 | 0.12 | 0.70 | 0.15 |
EBITDA | 73.91M | 15.76M | 36.03M | 40.32M | 87M | 37.23M |
EBIT | 46.97M | -1.26M | 12.58M | 22.29M | 70.32M | 29.04M |
Depreciation & Amortization | 26.94M | 17.03M | 23.45M | 18.03M | 16.68M | 8.18M |
Add to Watchlist
Select watchlists to add or remove ORGO